<DOC>
	<DOCNO>NCT01743014</DOCNO>
	<brief_summary>The purpose study determine whether combination ramipril clopidogrel lead improvement endothelial function , reduction oxidative stress reduction vascular inflammation , compare ramipril monotherapy , patient Diabetes Mellitus type 2 diabetic nephropathy .</brief_summary>
	<brief_title>Ramipril Clopidogrel Oxidative Stress , Vascular Inflammation Endothelial Dysfunction Type 2 Diabetes Diabetic Nephropathy</brief_title>
	<detailed_description>- Cardiovascular disease lead cause death diabetic population diabetic nephropathy . - Pharmacologic therapy patient diabetes hypertension regimen include either angiotensin-converting-enzyme inhibitor ( ACEi ) angiotensin receptor blocker ( ARB ) - Diabetic patient increase cardiovascular risk receive antiplatelet agent primary prevention . Methods : An open label , randomize , two period cross-over design study , involve patient type 2 diabetes diabetic nephropathy . After 4 week wash period ACE inhibitor Angiotensin receptor blocker ( week 0 , baseline ) 60 patient randomized receive ramipril ( 10 mg ) ramipril ( 10 mg ) clopidogrel ( 75mg ) 12 week exchange treatment 12 week , 2 week wash period clopidogrel . Patients examine measurement take baseline ( week 0 ) , end 12 , 14 , 26 week .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<criteria>type 2 diabetes patient diabetic nephropathy range micro macroalbuminuria HbA1c ( glycosylated haemoglobin A1c &lt; 7 % Blood pressure ≤130/80 mmHg LDL ( Low Density Lipoproteins ) &lt; 100 mg/dl Informed consent patient diabetic nephropathy estimate GFR &lt; 30ml/min Modification Diet Renal Disease equation ( MDRD equation ) baseline potassium &gt; 5.2 meq/L patient nephrotic proteinuria define albumine creatinine ratio ( ACR ) &gt; 3.5 g/g proteinuria &gt; 3.5 g per 1.73 m2 per 24 hour history evidence nondiabetic kidney disease history stroke , peripheral artery disease , coronary artery disease history evidence secondary form hypertension history severe hepatic failure , malignancy , severe endocrinopathy , autoimmune disease chronic inflammatory disease know bleed platelet disorder platelet &lt; 100.000/μL heart failure New York Heart Association ( NYHA ) functional class IIIV inability unwillingness part patient sign Patient Consent Form know hypersensitivity ramipril clopidogrel Women childbearing potential use oral anticoagulant antithrombotic treatment use glitazones patient receive statin stable dose least 3 month prior study initiation dose constant study surgical medical condition opinion investigator may expose patient high risk participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>diabetes</keyword>
	<keyword>diabetic nephropathy</keyword>
	<keyword>vascular inflammation</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>endothelial dysfunction</keyword>
	<keyword>Asymmetric dimethylarginine</keyword>
	<keyword>High sensitivity CRP</keyword>
	<keyword>albumine creatinine ratio</keyword>
	<keyword>isoprostane</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>ramipril</keyword>
	<keyword>carotid intima medium thickness</keyword>
</DOC>